1. Expression analysis of a panel of cancer-testis antigens in bladder cancer
- Author
-
Soudeh Ghafouri-Fard, Vahid Kholghi-Oskooei, Mohammad Hossein Modarressi, Mandana Afsharpad, Leila Nekoohesh, Hanie M Rad, Fatemeh Yazarlou, and Tamouchin Moharrami
- Subjects
Male ,0301 basic medicine ,Diagnostic information ,Urinary system ,Cell ,Kinesins ,urologic and male genital diseases ,03 medical and health sciences ,0302 clinical medicine ,Antigen ,Antigens, Neoplasm ,Testis ,Expression analysis ,Biomarkers, Tumor ,medicine ,Humans ,In patient ,Aged ,Pharmacology ,Bladder cancer ,business.industry ,Intracellular Signaling Peptides and Proteins ,Membrane Proteins ,RNA-Binding Proteins ,General Medicine ,Middle Aged ,medicine.disease ,Cystatins ,Gene Expression Regulation, Neoplastic ,030104 developmental biology ,medicine.anatomical_structure ,Urinary Bladder Neoplasms ,030220 oncology & carcinogenesis ,Cancer research ,Molecular Medicine ,Cancer/testis antigens ,Neoplasm Recurrence, Local ,Carrier Proteins ,Transcriptome ,business - Abstract
Aim: Cancer-testis antigens (CTAs) have specific expression in gametogenic tissues and aberrant expression in cancers. Materials & methods: We assessed expression of five testis-specific genes namely KIF2B, CST8, TMEM225, RBM46, OAZ3 in bladder cancer tissues, adjacent non-neoplastic tissues and urinary cell pellets (UCPs) of bladder cancer patients compared with nonmalignant conditions.Results: Expressions of all CTAs were higher in UCPs of bladder cancer patients compared with nonmalignant conditions. RBM46 expression in UCPs was higher in patients with recurrent tumors compared with primary tumors and in patients without hematuria compared with those having hematuria. TMEM225 expression in tumoral tissues was higher in high-grade tumors compared with low-grade tumors. Conclusion: Expression analysis of CTAs in UCP might provide diagnostic information about bladder cancer.
- Published
- 2018
- Full Text
- View/download PDF